Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Smoking on Salivary Inflammatory Cytokines (Interleukin (IL)-39, IL-41, IL-1β, TNF-α) in Periodontal Disease

NCT06528522 is registered in ClinicalTrials.gov with Necmettin Erbakan University as lead sponsor.

NCT NCT06528522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06528522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Smoking on Salivary Inflammatory Cytokines (Interleukin (IL)-39, IL-41, IL-1β, TNF-α) in Periodontal Disease
Lead sponsor
Necmettin Erbakan University
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2024
Completion date
September 15, 2024
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

periodontal diseases, periodontitis, adult, smoking